Clinical Trials · NCT01558271
A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 492
- Start date
- Mar 2012
- Locations
- 14 sites, Japan
- Primary endpoint
- Change From Baseline in Glycosylated Hemoglobin (HbA1c) at 26 Weeks